Transvenous endocardial pacing with SelectSecure™ 3830 lead in pediatric patients: case series of two infants and a literature review
C Yang, J Qi, M Alam, D Zou - BMC Cardiovascular Disorders, 2024 - Springer
Abstract Background The SelectSecure™ 3830 lead is an innovative, lumenless, and thin
active fixed lead with a nonretractable screw-in tip and a diameter of 4.1 Fr, making it the …
active fixed lead with a nonretractable screw-in tip and a diameter of 4.1 Fr, making it the …
Subcostal transversus abdominis plane block for epigastric cardiac pacemaker operation: A randomised controlled trial
JT Kim, J Min, JB Park, YE Jang - European Journal of …, 2025 - journals.lww.com
Method and results Ethics approval was provided by the Seoul National University Hospital
Institutional Review Board on September 24, 2020 (Chairperson, Prof. Byung-Joo Park; No …
Institutional Review Board on September 24, 2020 (Chairperson, Prof. Byung-Joo Park; No …
Permanent pacemaker implantation with hybrid endocardial perventricular approach in infancy: May be an alternative route in the absence of epicardial lead
Y Ergul, GT Sahin, HC Kafali… - Pacing and Clinical …, 2024 - Wiley Online Library
Despite the advancements in technology, establishing the optimal implantation technique for
pediatric patients with a pacemaker (PM) indication remains challenging. Although the …
pediatric patients with a pacemaker (PM) indication remains challenging. Although the …
[PDF][PDF] Transvenous endocardial pacing with SelectSecure
C Yang, J Qi, M Alam, D Zou - 2024 - bmccardiovascdisord.biomedcentral …
Background Implantation of permanent pacemakers in infants has become increasingly
necessary for decades in current clinical practice. Pacing electrodes for such patients must …
necessary for decades in current clinical practice. Pacing electrodes for such patients must …
Congenital Atrio-Ventricular Block: looking for optimal implantation timing. A single tertiary referral centre experience
G Papaccioli, GD Ciriello, A Correra, D Colonna… - 2024 - researchsquare.com
Background Congenital atrio-ventricular block (CAVB) affects 1 in 15,000 live births with a
mortality rate of 16–30%. It can be associated with congenital heart disease (CHD) or …
mortality rate of 16–30%. It can be associated with congenital heart disease (CHD) or …
КРЕАТИВНАЯ КАРДИОЛОГИЯ
КВ ШАТАЛОВ, СЮ СЕРГУЛАДЗЕ… - … хирургии им. АН …, 2024 - elibrary.ru
Имплантация электрокардиостимулятора (ЭКС) является одним из основных методов
лечения при нарушении атриовентрикулярной проводимости, при синдроме слабости …
лечения при нарушении атриовентрикулярной проводимости, при синдроме слабости …
Thoracoscopic epicardial lead implantation
KV Shatalov, SY Serguladze, MA Abdurazakov… - cardiology-journal.com
Resynchronization therapy is the main treatment option in patients with atrio-ventricular
block, sick sinus syndrome and other cardiac rhythm dysfunction. Cardiac resynchronization …
block, sick sinus syndrome and other cardiac rhythm dysfunction. Cardiac resynchronization …